X

LATEST

Fundamental Research Corp. raises Ocean Biomedical’s price target to $17.63 per share

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Wednesday said that Fundamental Research Corp. increased the price target of the company’s stock…

Initial response to single-serve pour-over product is the driver behind NuZee’s business: CEO

NuZee, Inc. (NASDAQ: NUZE) is a leading coffee technology and co-packing company that provides end-to-end sustainable solutions for clients ranging…

Ocean Biomedical’s scientific co-founder Dr. Jonathan Kurtis gets new patent for malaria vaccine

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company focused on clinical programs in oncology, fibrosis, and infectious disease, Thursday said…

Taglich Brothers initiates coverage of Ocean Biomedical, with price target of $20

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday revealed that Taglich Brothers initiated coverage on the company with a…

Ocean Biomedical (OCEA) set to join the Russell 2000 Index

Biopharmaceutical company Ocean Biomedical (NASDAQ: OCEA) on Thursday said it is expected to be added to the Russell 2000 Index,…

Ocean Biomedical (OCEA) announces patent award for novel cancer immunotherapy treatment

Biopharma company Ocean Biomedical (NASDAQ: OCEA) on Tuesday said its scientific co-founder Dr. Jack Elias has been issued a broad…

Ocean Biomedical announces private placement of $25 mln convertible notes

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it has entered into a private placement pursuant to a…

MCHP Earnings: Microchip Technology Q4 2023 sales and profit increase

Microchip Technology Inc. (NASDAQ: MCHP) has announced financial results for the fourth quarter of 2023, reporting a 21% growth in…

H&R Block, Inc. (HRB) Q3 2023 Earnings Call Transcript

H&R Block, Inc. (NYSE: HRB) Q3 2023 Earnings Call dated May. 09, 2023 Corporate Participants: Michaella Gallina -- Vice President…

Apple (AAPL) Q2 2023 sales down 3%; results beat estimates

Gadget giant Apple Inc. (NASDAQ: AAPL) on Thursday said its second-quarter 2023 sales declined from last year, reflecting lower Mac…

Advanced Micro Devices sees recovery in second half. Is the stock a buy?

Semiconductor company Advanced Micro Devices, Inc. (NASDAQ: AMD) had an unimpressive start to the new fiscal year, reporting weak numbers…

Shake Shack Inc Class A (SHAK) Q1 2023 Earnings Call Transcript

Shake Shack Inc Class A (NYSE: SHAK) Q1 2023 Earnings Call dated May. 04, 2023 Corporate Participants: Annalee Leggett -- Director of…

Blue Apron Holdings Inc (APRN) Q1 2023 Earnings Call Transcript

Blue Apron Holdings Inc (NYSE: APRN) Q1 2023 Earnings Call dated May. 04, 2023  Corporate Participants: Linda Findley Kozlowski --…

Papa Johns International Inc (PZZA) Q1 2023 Earnings Call Transcript

Papa Johns International Inc (NASDAQ:PZZA) Q1 2023 Earnings Call dated May. 04, 2023 Corporate Participants: Stacy Frole -- Vice President of Investor…

Trxade Health Inc. (NASDAQ: MEDS) Q1 2023 Research Summary

Trxade Health Inc. (NASDAQ: MEDS) is a healthcare IT company that operates as an integrated drug procurement and delivery platform.…

Ocean Biomedical reports new results validating tumor suppression with anti-Chi3L1 antibody: EF Hutton raises OCEA price target to $17

Biopharmaceutical company Ocean Biomedical (NASDAQ: OCEA) on Thursday said its scientific co-founder Jack Elias published new findings in Cancer Research,…

Ocean Biomedical co-founder Jonathan Kurtis presents detailed data on malaria vaccine at conference

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biopharma company that works with research universities and medical centers for developing and…

Ocean Biomedical co-founder Jack Elias to receive US patent for pulmonary fibrosis treatments

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biopharma company that works with research universities and medical centers for developing and…

JB Hunt Transport Services Inc. (JBHT) Q1 2023 Earnings Call Transcript

JB Hunt Transport Services Inc. (NASDAQ: JBHT) Q1 2023 earnings call dated Apr. 17, 2023 Corporate Participants: Brad Delco -- Senior Vice…

Ocean Biomedical (OCEA) announces $134 million financial backing for innovative research and IND filings

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company that works with research universities and medical centers for developing and commercializing…

Continued focus on core B2B segment drives new business: Trxade CEO Suren Ajjarapu

Trxade Health Inc. (NASDAQ: MEDS), a leading online drug procurement marketplace, is on a mission to provide independent pharmacies a…